Venom Allergen Immunotherapy in Children: Short-term Efficacy and Impact on Quality of Life.

Background: Hymenoptera venom allergy (HVA) is a potentially life-threatening reaction to stings from Apis mellifera (honeybee) or Vespula (yellowjacket).

Objective: We aimed to evaluate re-sting reactions during or after venom immunotherapy (VIT) and the impact of VIT on the quality of life (QoL) of children with HVA.

Methods: Seventy-eight patients who experienced grade 3, 4, or 5 systemic reactions and underwent conventional subcutaneous VIT were included.